Establishment Labs Holdings Inc. (ESTA)
NASDAQ: ESTA · Real-Time Price · USD
38.91
+1.47 (3.93%)
Jun 16, 2025, 4:00 PM - Market closed
Company Description
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.
The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders.
The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America.
Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Establishment Labs Holdings Inc.
Country | Costa Rica |
Founded | 2004 |
IPO Date | Jul 19, 2018 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 1,018 |
CEO | Fillipo Caldini |
Contact Details
Address: Building B23 and B25, Coyol Free Zone Alajuela Costa Rica | |
Phone | 506 2434 2400 |
Website | establishmentlabs.com |
Stock Details
Ticker Symbol | ESTA |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001688757 |
CUSIP Number | G31249108 |
ISIN Number | VGG312491084 |
Employer ID | 98-1436377 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Fillipo Peter Caldini | Chief Executive Officer and Director |
Juan Jose Chacon Quiros | Founder and Executive Director |
Rajbir Singh Denhoy | Chief Financial Officer |
S. Ross Mansbach | General Counsel, Chief Compliance Officer and Chief Human Resources Officer |
Roberto de Mezerville | Chief Technology Officer |
Rosalyn Cole d'Incelli | SVice President of Global Clinical, Medical and US Regulatory Affairs |
Ivan Bilic | Senior Vice President of Commercial Operations - OUS |
Jeff Ehrhardt | Senior Vice President and GM of North America |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jun 12, 2025 | 8-K | Current Report |
May 27, 2025 | 8-K | Current Report |
May 22, 2025 | 8-K | Current Report |
May 21, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
May 13, 2025 | SCHEDULE 13G/A | Filing |
May 9, 2025 | 10-Q | Quarterly Report |
May 7, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
May 7, 2025 | 8-K | Current Report |
May 7, 2025 | 8-K | Current Report |
Apr 10, 2025 | ARS | Filing |